By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CoGenesys, Inc. 

Rockville  Maryland    U.S.A.
Phone: 240-314-4419 Fax:


Start Up

Company News
Craig Rosen, Ph.D., Biopharmaceutical Development Expert, Joins Phase Bioscience, Inc. as Executive Chairman 10/9/2008 9:30:55 AM
Teva Pharmaceutical Industries Limited (TEVA) Says to Acquire CoGenesys, Inc. for $400 Million 1/22/2008 6:51:38 AM
Vegenics Limited Licenses From CoGenesys, Inc. Antibodies Against VEGF-C for Applications Including Oncology 6/18/2007 10:40:05 AM
CoGenesys, Inc. Announces the Achievement of Milestones Under License Agreements With PDL BioPharma, Inc. (PDLI) and Vegenics Limited 5/23/2007 12:30:40 PM
CoGenesys, Inc. Expands Clinical Programs with Initiation of Phase 1-2a Trial of Neugranin in Cancer Patients 3/27/2007 11:10:21 AM
The Day In Review: Two Big Deals To Start The New Year 1/3/2007 6:32:13 PM
CoGenesys, Inc. Files To Begin Clinical Trials Of Neugranin For The Prevention Of Infections In Cancer Patients 1/3/2007 2:03:42 PM
Dr. David U'Prichard Joins CoGenesys, Inc. Board Of Directors 12/19/2006 10:10:01 AM
CoGenesys, Inc. Initiates Phase 1-2 Clinical Trial Of Cardeva In Patients With Heart Failure 10/11/2006 10:33:18 AM
CoGenesys, Inc. Announces Worldwide License Agreement With Vegenics Limited 8/21/2006 8:01:57 AM